Deconstruction of the α4β2 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Desformylflustrabromine

Journal of Medicinal Chemistry
2011.0

Abstract

Desformylflustrabromine (dFBr; 1), perhaps the first selective positive allosteric modulator of α4β2 neuronal nicotinic acetylcholine (nACh) receptors, was deconstructed to determine which structural features contribute to its actions on receptors expressed in Xenopus ooycytes using two-electrode voltage clamp techniques. Although the intact structure of 1 was found to be optimal, several deconstructed analogs retained activity. Neither the 6-bromo substituent nor the entire 2-position chain is required for activity. In particular, reduction of the olefinic side chain of 1, as seen with 6, not only resulted in retention of activity/potency but in enhanced selectivity for α4β2 versus α7 nACh receptors. Pharmacophoric features for the allosteric modulation of α4β2 nACh receptors by 1 were identified.

Knowledge Graph

Similar Paper

Deconstruction of the α4β2 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Desformylflustrabromine
Journal of Medicinal Chemistry 2011.0
Synthesis of desformylflustrabromine and its evaluation as an α4β2 and α7 nACh receptor modulator
Bioorganic & Medicinal Chemistry Letters 2007.0
Prenylated Indole Alkaloids fromFlustra foliaceawith Subtype Specific Binding on NAChRs
Planta Medica 2004.0
Prenylated Indole Alkaloids from<i>Flustra foliacea</i>with Subtype Specific Binding on NAChRs
Planta Medica 2004.0
Conformationally restrained carbamoylcholine homologues. Synthesis, pharmacology at neuronal nicotinic acetylcholine receptors and biostructural considerations
European Journal of Medicinal Chemistry 2015.0
Synthesis and evaluation of N1-alkylindole-3-ylalkylammonium compounds as nicotinic acetylcholine receptor ligands
Bioorganic &amp; Medicinal Chemistry 2012.0
Synthesis, Pharmacology, and Biostructural Characterization of Novel α<sub>4</sub>β<sub>2</sub>Nicotinic Acetylcholine Receptor Agonists
Journal of Medicinal Chemistry 2013.0
Exploration of the molecular architecture of the orthosteric binding site in the α4β2 nicotinic acetylcholine receptor with analogs of 3-(dimethylamino)butyl dimethylcarbamate (DMABC) and 1-(pyridin-3-yl)-1,4-diazepane
European Journal of Medicinal Chemistry 2015.0
Novel Acetylcholine and Carbamoylcholine Analogues: Development of a Functionally Selective α<sub>4</sub>β<sub>2</sub>Nicotinic Acetylcholine Receptor Agonist
Journal of Medicinal Chemistry 2008.0
Carbamoylcholine analogs as nicotinic acetylcholine receptor agonists—Structural modifications of 3-(dimethylamino)butyl dimethylcarbamate (DMABC)
Bioorganic &amp; Medicinal Chemistry Letters 2009.0